Pharmacom Corporation consists of three functional groups and business entities which operate at Europe, Asia and America respectively. Pharmacom Therapeutics Inc. discoveries and identifies molecular, subcellular and cellular targets for the biodetection microsystem; Pharmacom Bioinformatics Inc. designs and develops software for the biodetection microsystem, and Pharmacom Microelectronics Inc. engineers and manufactures hardware for the biodetection microsystem.

Pharmacom Therapeutics focuses on identifying and characterizing the biomarkers of infectious diseases, the signature molecules of cancers, the epidemical factors of allergies, and the metabolic pathways of food, drink, beverage and drug substances.

Pharmacom Bioinformatics aims at developing a variety of pharmaceutical data automation systems, which capture data in vitro, in vivo and on silica; interpret data at genomic, transcriptomic and proteomic levels; represent data based on gene sequences, protein patterns, compound attributes and molecule character and uniqueness.

Pharmacom Microelectronics is specialized on developing real-time screening, detecting and interpreting microsystems that provide the support in infectious disease detection, pathogen identification, food and beverage safety inspection, pharmaceutical compound discovery, environment monitoring, and bioterrorism activity indication.